Since the FDA announced that tirzepatide is (for now) out of shortage, APC’s Scott Brunner has been...
As the fallout (and questions) of the official end to the tirzepatide shortage continues, news outlets are continuing to turn to APC for compounders’ perspective. Medscape is the latest, and it quotes CEO Scott Brunner extensively.
Since the FDA announced that tirzepatide is (for now) out of shortage, APC’s Scott Brunner has been...
CNN’s Meg Tirrell gets to the heart of the matter in “The end of a shortage of popular weight-loss...
The Reuters story, “Novo's Wegovy and Ozempic removed from US FDA shortage list, compounders on...